Rx-360 Announces 2020 Board of Directors
PHILADELPHIA, Dec. 20, 2019 /PRNewswire/ -- Rx-360 is pleased to announce their 2020 Board of Directors. The Board of Directors is positioned to continue driving the Rx-360 mission of pharmaceutical supply chain security and patient safety. This announcement follows the successful growth of the organization and this past year's celebration of their Ten-Year Anniversary. The Rx-360 Consortium operates internationally through its member driven Working Groups and successful Audit Program. The 2020 Board of Directors includes:
Tim Valko (Chair):
Lucy Cabral (Vice Chair):
Rob Welsh (Treasurer):
Scott Kammer (Secretary):
Johnson and Johnson
Sartorius-Stedim North America
MilliporeSigma (Merck KGaA)
*Newly appointed for 2020
Tim Valko the Rx-360 Board Chair expressed, "On behalf of Rx-360, our Board of Directors and the patients we serve, I am pleased to welcome our three new Board Members Christian Liebl, Brenda McKown, and Stephan Peeters, we look forward to a great 2020". Jim Fries, Rx-360 CEO, added, "The experience that our Board brings to not only the Rx-360 membership, but the industry as a whole truly signals the importance of supply chain security and patient safety."
Rx-360, an international pharmaceutical supply chain consortium, was formed in 2009 to support an industry-wide commitment to ensuring patient safety by enhancing quality and authenticity throughout the supply chain. The organization's mission is to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain.. To learn more about Rx-360, please visit http://www.Rx-360.org or email Jim Fries at [email protected].
View original content to download multimedia:http://www.prnewswire.com/news-releases/rx-360-announces-2020-board-of-directors-300977646.html